Course Director: 
Dr. Kenneth Cohen
Series date: 
Sunday, July 1, 2018 - 12:00pm to Sunday, June 30, 2019 - 1:00pm

Accreditation Statement

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement 

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Series location: 
UCMC KCBD
Chicago, IL 60637
United States

Sessions

Session Datesort descending
“Center for Clinical Cancer Genetics: 2018 Program Update” 10/08/2018 - 12:00pm to 1:00pm
“Targeting the Beta-Catenin Pathway to Overcome Immunotherapy Resistance of Beta-catenin Expressing Tumors” and “Diving into the Deep End: Minimal Residual Disease in Multiple Myeloma” 10/15/2018 - 12:00pm to 1:00pm
“The Role of Bacterial Driven Inflammation in TET2 Mutated Clonal Hematopoiesis: Update and Future Directions” and “Clinical and Molecular Correlates of Immunotherapy Response and Resistance” 10/22/2018 - 12:00pm to 1:00pm
“The Impact of PTEN-Deficiency on Immunotherapy Response: Current Understanding and Future Directions” and “A Spotlight on the Hematologic Toxicities of Immune Checkpoint Inhibitors” 10/29/2018 - 12:00pm to 1:00pm
“Utilizing Pharmacogenomics to Risk-Mitigate Chemotherapy-Related Toxicities” and “Brewing SolutionsTo the “Cold” Tumor Microenvironment: A Role for the A2A Adenosine Receptor?” 11/05/2018 - 12:00pm to 1:00pm
“Targeting Cellular Metabolism Through Modulation of BACH1 in Triple-Negative Breast Cancer” 11/12/2018 - 12:00pm to 1:00pm
“Healthcare Resource Allocation: Ethically Addressing U.S. Medication & Personnel Scarcity” 11/19/2018 - 12:00pm to 1:00pm
“The HNC Program: What it takes to Change the Standard of Care” 11/26/2018 - 12:00pm to 1:00pm
“Identifying Oncogenic Pathways that Mediate Evasion from Anti-Tumor Immunity” 12/10/2018 - 12:00pm to 1:00pm
“Putting the Brakes on the CAR T: Management of CAR T Toxicities” and “Factors Impacting Outcomes in Adolescent & Young Adults (AYA) with Hematologic Malignancies” 12/17/2018 - 12:00pm to 1:00pm

Pages